7,435
Participants
Start Date
February 15, 2022
Primary Completion Date
July 24, 2024
Study Completion Date
July 12, 2025
Freenome Test
Participants who provide informed consent, meet the eligibility criteria and provide a blood sample for this study will be enrolled.
NYU, New York
White Plains Hospital, White Plains
NY Cancer & Blood Specialists, Port Jefferson Station
Pennsylvania Cancer Specialists & Research Institute, Gettysburg
Cancer Care Associates of York (QCCA), York
Donald Guthrie Foundation, Sayre
Doylestown Health, Doylestown
Thomas Jefferson University, Philadelphia
USDH Clinical Research, Wyomissing
Mercy Medical Center, Baltimore
Objective Health Network, Richmond
Centra Lynchburg Hematology Oncology, Lynchburg
Carolina Blood and Cancer Care Associates, Rock Hill
Morehouse School of Medicine, Atlanta
Specicare, Gainesville
Cancer Center of Middle Georgia (QCCA), Dublin
Emerald Coast OBGYN, Panama City
Ascension Sacred Heart, Pensacola
Mid Florida Hematology & Oncology Center, Orange City
RecioMed Clinical Research, Boynton Beach
Central Alabama Research, Birmingham
Alabama Oncology, Birmingham
ObjectiveHealth, Inc, Franklin
Saint Joseph Cancer Center, Lexington
Gabrail Cancer Center Research, Canton
Objective Health Network, Dayton
Objective Health Network (Digestive Research Alliance of Michiana, LLC), South Bend
University of Michigan, Ann Arbor
Ascension Providence Rochester Hospital, Rochester Hills
Covenant HealthCare, Saginaw
SSM Health-Dean Medical Group, Madison
University of Minnesota, School of Public Health, Environmental Health Sciences, Minneapolis
Avera Cancer Institute, Sioux Falls
Altru Health System, Grand Forks
Billings Clinic, Billings
Logan Health Research, Kalispell
Northwest Oncology & Hematology, Rolling Meadows
University of Chicago, Chicago
Central Care Cancer Center, Bolivar
Ascension Via Christi Hospital, Wichita, Wichita
Louisiana State University Health Sciences Center, Shreveport
Louisiana Research Center, LLC, Shreveport
Highlands Oncology Group, Springdale
Hightower Clinical Research, Oklahoma City
Christus Trinity Mother Frances Health System, Tyler
Oncology Consultants, Houston
The University of Texas M.D. Anderson Cancer Center, Houston
Christus Spohn Shoreline Hospital, Corpus Christi
Honor Health, Scottsdale
Urology Alliance Clinical Research, Los Angeles
Torrance Memorial Physician Network - Cancer Care, Torrance
Pomona Valley Hospital Medical Center/Cancer Care Center, Pomona
San Diego Clinical Trials, La Mesa
Miller Bioconnect, El Cajon
Gastroenterology and Liver Institute, Escondido
Carbon Health, Corona
Women's Cancer Network, Fresno
Cancer Care Specialists Reno, Reno
St. Mary's Medical Center, San Francisco
John Muir Health, Concord
Dominican Hospital Dignity Health, Santa Cruz
Stockton Hematology Oncology, Stockton
Mercy Cancer Center, Merced
St. Charles Health System, Inc, Bend
Northwest Medical Specialties (QCCA), Tacoma
Eastern CT Hematology and Oncology Associates, Norwich
Massachusetts General Hospital, Boston
Inspira Medical Center Vineland, Vineland
Freenome Holdings Inc.
INDUSTRY